Evonik schedules November 3 results for Evonik stock

Published on 10/26/2026 at 16:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evonik's adjusted EBITDA rose 24.00 percent to EUR 630.00 million. Evonik stock costs EUR 21.31 on October 26, 2026, up 0.24 percent versus the Xetra close.

Reporting date and earnings

Evonik scheduled its third-quarter 2026 report for November 3, 2026.
Adjusted EBITDA rose 24.00 percent to EUR 630.00 million in the second quarter of 2026.
Evonik stock costs EUR 21.31 at Lang & Schwarz on October 26, 2026 at 4:42 p.m. CET, 0.24 percent above the Xetra close of October 23, 2026.
The 52-week high is EUR 21.84, leaving the stock 2.43 percent below that level.

Evonik, DE000EVNK013, Illustration mit AI erstellt.

Evonik scheduled its third-quarter 2026 report for November 3, 2026, according to Evonik. The stock was trading at EUR 21.31 at Lang & Schwarz on October 26, 2026 at 4:42 p.m. CET, up 0.24 percent versus the Xetra close of October 23, 2026 at EUR 21.26.

Second-quarter earnings set the backdrop

Evonik's adjusted EBITDA rose 24.00 percent year over year to EUR 630.00 million in the second quarter of 2026, while revenue reached EUR 3.893 billion, according to Feed Planet Magazine. The reported adjusted EBITDA margin was 16.20 percent, giving the November report a clear earnings baseline.

Stock stays near its yearly high

Evonik's 52-week range was EUR 12.49 to EUR 21.84 as of October 26, 2026. At EUR 21.31, the stock stood 2.43 percent below the high and 70.62 percent above the low; trading volume was 307,157 shares, and market capitalization was EUR 9.9 billion.

Valuation meets a November date

The price-to-earnings ratio was 82.21 and the dividend yield was 0.05 percent as of October 26, 2026. The next scheduled company report is the third-quarter update on November 3, 2026, which gives investors the next dated checkpoint for margins, cash flow and the full-year outlook.

Comparison with peers

Evonik: up 0.24 percent, P/E 82.21, market capitalization EUR 9.9 billion.
BASF (Xetra, EUR): down 0.44 percent, P/E 7.84, market capitalization EUR 45.0 billion.
Covestro (Frankfurt, EUR): unchanged at 0.00 percent, P/E minus 23.70, market capitalization EUR 12.5 billion.

The next market check

The immediate stock picture combines a small intraday gain with a position near the 52-week high and a scheduled earnings date. The November 3 report will show whether the second-quarter improvement in adjusted EBITDA is continuing.

The stock was trading at EUR 21.31 at Lang & Schwarz on October 26, 2026 at 4:42 p.m. CET, 0.24 percent above the Xetra close of October 23, 2026 at EUR 21.26. The further course of trading is shown by the continuously updated real-time quote of Evonik stock.